Whiplash Injury Market

Key Highlights

 

• Whiplash is the most common injury in road accidents, particularly for motorists: over the 2007–2010 period (French road safety database), 35% of injured car occupants were concerned. A study of drivers in collisions involving two cars found similar results in French (1997–2003) and Spanish databases (2002–2004): 12.2% were diagnosed with whiplash in France and 12% in Spain (Tournier et al., 2016).

 

• The Whiplash Injury epidemiology is segmented as Total Prevalent Cases of Whiplash Injury, Gender-specific Prevalent Cases of Whiplash Injury, Age-specific Prevalent Cases of Whiplash Injury, Severity-specific Cases of Whiplash Injury in the 7MM covering the United States, EU4 countries (Germany, France, Italy, and Spain), the United Kingdom, and Japan from 2019 to 2032.

 

Request a sample for unlocking the CAGR of Whiplash Injury Market

 

DelveInsight’s “Whiplash Injury Market Insights, Epidemiology, and Market Forecast – 2032” report delivers an in-depth understanding of the Whiplash Injury, historical and forecasted epidemiology as well as the Whiplash Injury market trends in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.

 

The Whiplash Injury market report provides current treatment practices, emerging drugs, Whiplash Injury market share of the individual therapies, and current and forecasted Whiplash Injury market size from 2019 to 2032, segmented by seven major markets. The report also covers current Whiplash Injury treatment practices/algorithms and Whiplash Injury unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

 

Geography Covered

• The United States
• EU4 (Germany, France, Italy, Spain), and the United Kingdom
• Japan

 

Study period: 2019–2032

 

Whiplash Injury Market Disease: Understanding and Treatment Algorithm

 

The DelveInsight’s Whiplash Injury market report gives a thorough understanding of Whiplash Injury by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment. 

 

According to the United Kingdom National Health Service, Whiplash is a neck injury caused by sudden movement of the head. It usually gets better within 2 to 3 months.

 

The injury is usually caused from the blow to the back of the automobile in which the individual is riding, thus causing the forward movement of the body which is followed by a quick back-snapping of the head region. This leads to the injury in the neck region. Other reasons associated for a whiplash injury might involve an impact or a blow which causes the head region to jerk forwards and backwards, thus leading to the straining of the neck. The sudden force leads to stretching or tearing of the muscles and tendons in the neck region. 

 

Whiplash is reported to generate both short- and long-term consequences, such as neck pain, headache, dizziness, sensory disorder and reduced neck mobility. These symptoms are often grouped together as “whiplash-associated disorder” (WAD).

 

An acute whiplash injury follows sudden or excessive hyperextension, hyperflexion, or rotation of the neck affecting the soft tissues. It typically results from rear-end or side-impact motor vehicle collisions. Patients commonly present with pain and stiffness in the neck, headache, and upper backache with or without paraesthesia of the upper limbs. Chronic whiplash syndrome is characterized by symptoms that persist for more than 3 months.

 

Whiplash Injury Diagnosis

In terms of diagnosis, fractures of the vertebrae are rare but may be imaged easily using such modalities as plain radiography, MRI and CT scans. However, the majority of injuries are more likely to be soft tissue trauma, which is not always identifiable and, as patients rarely undergo surgery, these injuries often remain undetected. Radiological investigations in the acute phase can lead to a large number of false-positive cases. It is important to avoid over investigating; these should be held in reserve for patients with ‘Red flag’ features or for those with persistent problems of pain down the arms. Pre-existing degenerative cervical spine disease (especially spondylosis at the C5/6 level) is the most common finding seen radiologically in patients complaining of whiplash injury.

 

Whiplash Injury Treatment

Current evidence supports early mobilization, simple analgesics, reassurance, and active interventions as the best treatment options for WAD I–III. Immediate specialist referral should be made for severe symptomatic WAD III and for all patients with WAD IV. Recovery from whiplash injury can be predictable in most cases. Most patients who are symptomatic at 3 months remain so indefinitely, especially if psychosocial and economic factors are involved. 

 

Whiplash Injury Epidemiology 

The Whiplash Injury epidemiology section provides insights into historical and current Whiplash Injury patient pool and forecasted trends for seven individual major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Whiplash Injury report also provides the diagnosed patient pool, their trends and assumptions undertaken.

 

Key findings

 

• In a study by Oka et al., 4,164 participants reported being injured in a traffic collision, of whom 37.7% were diagnosed with WAD. The study also clarified the age-gender distribution of WAD in the Japanese population. If the results are extrapolated to the Japanese population using the 2010 census data, approximately 980,000 persons (590,000 male and 390,000 female) aged 20 years and older are affected by WAD [2017].

 

• The study by Crouch et al. demonstrated that approximately 1 in 125 new patients attending the emergency department will have whiplash associated disorder in the UK. This compares with an estimate of 1 in 200 people having minor neck injury of whiplash each year. The study identified that there is significant disability associated with whiplash. Two thirds of patients in this study had some disability at four to six weeks after the injury as measured by the Neck Disability Index (NDI). More than half visited their GP in the month following their visit to the emergency department. This is in line with research which shows that 50% of patients do not recover by three months [2006].

 

• The incidence of WAD in the United States is probably into the millions, and approximately half of those with WAD continue to report neck pain 1 year after their injuries. In fact, Freeman et al. estimated, from a case-control study comprised of 419 chronic neck pain cases and 246 chronic low back pain controls, that about 6.2% of the US population may have chronic neck pain attributable to a whiplash injury [2016].

 

• Whiplash is the most common injury in road accidents, particularly for motorists: over the 2007–2010 period (French road safety database), 35% of injured car occupants were concerned. A study of drivers in collisions involving two cars found similar results in French (1997–2003) and Spanish databases (2002–2004): 12.2% were diagnosed with whiplash in France and 12% in Spain (Tournier et al., 2016).

 

• The Whiplash Injury epidemiology covered in the report provides historical as well as forecasted Gingival recession epidemiology [segmented as Total Prevalent Cases of Whiplash Injury, Gender-specific Prevalent Cases of Whiplash Injury, Age-specific Prevalent Cases of Whiplash Injury, Severity-specific Cases of Whiplash Injury in the 7MM covering the United States, EU4 countries (Germany, France, Italy, Spain), the United Kingdom, and Japan from 2019 to 2032.

 

Country-wise Whiplash Injury Epidemiology

The epidemiology segment also provides the Whiplash Injury epidemiology data and findings across the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.

 

Whiplash Injury Drug Chapters

The drug chapter segment of the Whiplash Injury report encloses the detailed analysis of Whiplash Injury marketed drugs and late-stage (Phase III and Phase II) Whiplash Injury pipeline drugs. It also helps understand the Whiplash Injury clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug, and the latest news and press releases.

 

Whiplash Injury Market Outlook

Whiplash injuries are quite difficult to treat because of interactions of various factors such as patient psychology, socioeconomic factors, legal issues, and physical health. The absence of radiological evidence of injury in the symptomatic group further complicates the treatment process for this condition. It was traditionally believed that bed rest and immobilization of the neck with a soft collar was the initial treatment of choice, but this has been refuted. Reassurance, resuming activity as normal, early mobilization, physiotherapy along with isometric exercise with periods of rest intermittently have been associated with better long-term outcomes.

 

Acute/subacute whiplash injury

Acute whiplash injury is defined as symptoms present up to 4 weeks and subacute whiplash when symptoms persist beyond 4 weeks until 12 weeks. Mobilization is more effective if started within 96 h of the injury. A better range of neck movements at 2 weeks has been reported when non-steroidal anti-inflammatory drugs (NSAIDS) have been used. Patients receiving high-dose methylprednisolone within 8 h of injury have fewer disabling symptoms at 6 months and fewer sick leave days but is not recommended in WAD I–III. Other physical treatments such as heat and cold packs, pulsed electromagnetic field therapy, hydrotherapy, traction, ultrasound therapy, laser therapy, short-wave diathermy, transcutaneous electrical nerve stimulation, acupuncture, and passive repetitive movements have been tried with variable benefit. There is some evidence that a multimodal treatment approach of postural training, eye fixation exercises, manual treatment, and psychological support may be more beneficial than physical therapy at both symptom improvement and functional improvement. Recent work indicates standardized multidisciplinary rehabilitation program aimed at fostering functional recovery may reduce pain catastrophizing in patients with subacute pain after whiplash injury. Various analgesics, antidepressants (especially amitriptyline), and muscle relaxants such as diazepam, azapropazone, epidural local anaesthetics, and epidural corticosteroids have been used. Muscle relaxants are not recommended in the acute phase.

Chronic whiplash injury

 

Many interventions have been tried for chronic whiplash injuries; of which, cervical radiofrequency neurotomy (CRFN) facet joints have shown reasonable relief from pain for up to 9 months. Some studies have reported a benefit in nearly 70% of the patients from CRFN. Other interventions like cervical facet joint injections have been used with short-term benefit. Intra-articular corticosteroids, temporomandibular joint treatment, cervical traction, and botulinum toxin injections have been described in the literature, with evidence lacking to support their use currently. A multimodal approach to treatment including cognitive behavior therapy along with physical and or mechanical therapy and patient education is more effective at 3 months with a higher percentage of patients being satisfied with their pain management when compared with only physical treatment. For symptom management, along with simple analgesics, patients may be commenced on anti-neuropathic medications according to NICE clinical guideline.

 

Key findings

 

This section includes a glimpse of the Whiplash Injury market in 7MM.

 

The United States: Whiplash Injury Market Outlook

This section provides the total Whiplash Injury market size and market size by therapies in the United States.

 

EU4 and the UK Countries: Whiplash Injury Market Outlook

The total Whiplash Injury market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom are provided in this section.

 

Japan: Whiplash Injury Market Outlook

The total Whiplash Injury market size and market size by therapies in Japan are also mentioned.

 

Whiplash Injury Drug Uptake

 

This section focuses on the rate of uptake of the potential drugs recently launched in the Whiplash Injury market or expected to get launched in the market during the study period 2019–2032. The analysis covers Whiplash Injury market uptake by drugs, patient uptake by therapies, and sales of each drug.  

 

This will help in understanding the Whiplash Injury drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in the market uptake and in making financial and regulatory decisions.

 

Whiplash Injury Pipeline Development Activities

 

The report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Whiplash Injury’s key players involved in developing targeted therapeutics.

 

Whiplash Injury Clinical Trial development activities

 

The report covers detailed information on collaborations, acquisitions, and mergers, licensing patent details, and other information for Whiplash Injury emerging therapies.

 

Whiplash Injury Reimbursement Scenario

 

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we consider reimbursement to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

 

KOL Views

 

To keep up with current epidemiology and market trends, we take KOLs and SMEs' opinions working in the Whiplash Injury domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies and treatment patterns along with Whiplash Injury market trends. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the market and the Whiplash Injury unmet needs.

 

Competitive Intelligence Analysis

 

We perform competitive and market intelligence analysis of the Whiplash Injury market by using various competitive intelligence tools that include – SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies, etc. The inclusion of the analysis entirely depends upon the data availability.

 

Whiplash Injury Market Report Scope

• Descriptive overview of Whiplash Injury, disease overview, patient journeys, treatment algorithms, diagnosis, and currently available therapies
• Comprehensive insight into the Whiplash Injury epidemiology and forecasts in the 7MM
• An all-inclusive account of both the current and emerging therapies for Whiplash Injury, along with the assessment of new therapies, expected to have an impact on the current treatment landscape
• Exhaustive analysis of the Whiplash Injury market; historical and forecasted covering drug outreach in the 7MM
• Detailed patient-based Whiplash Injury market forecasting determines the trends shaping and driving the global Whiplash Injury market

 

Whiplash Injury Market Report Highlights

• In the coming years, the Whiplash Injury market is set to change due to the rising awareness of the disease and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Whiplash Injury R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition   
• Major players are involved in developing Whiplash Injury therapies. The launch of emerging therapies will significantly impact the Whiplash Injury market
• A better understanding of Whiplash Injury pathogenesis will also contribute to the development of novel therapeutics for Whiplash Injury
• Our in-depth analysis of the Whiplash Injury pipeline assets across different stages of development (Phase III and Phase II), emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

 

Whiplash Injury Report Insights

• Patient-Based Whiplash Injury Market Forecasting 
• Therapeutic approaches
• Whiplash Injury pipeline analysis
• Whiplash Injury market size and trends
• Whiplash Injury market opportunities
• Impact of upcoming therapies

 

Whiplash Injury Report Key Strengths

• 11 years forecast
• 7MM Coverage
• Whiplash Injury epidemiology segmentation
• Key cross competition
• KOL views
• Whiplash Injury drugs uptake

 

Whiplash Injury Report Assessment

• Current treatment practices
• Unmet needs
• Whiplash Injury pipeline product profiles
• Whiplash Injury market attractiveness

 

Key Questions

 

Whiplash Injury market insights:

• What would be the Whiplash Injury market growth till 2032, and what will be the resultant market size in 2032?
•  What was the Whiplash Injury drug class share (in percentage) distribution in 2019, and how would it look in 2032?
• What would be the Whiplash Injury total market size and market size by therapies across the 7MM during the forecast period (2019–2032)?
• What are the key findings of the market across 7MM, and which country will have the largest Whiplash Injury market size during the forecast period (2019–2032)
• How would the unmet needs affect the Whiplash Injury market dynamics and subsequent analysis of the associated trends?

 

Whiplash Injury Epidemiology Insights:

• What are the disease risk, burden, and regional/ethnic differences of Whiplash Injury?
• What is the historical and forecasted Whiplash Injury patient pool in 7MM, and where can one observe the highest patient population and growth opportunities? 
• What are the key factors driving the epidemiology trends for seven major markets covering the United States, EU4 (Germany, Spain, France, Italy), the UK, and Japan?

 

Current Treatment Scenario, Marketed Drugs, and Emerging Therapies

• What are the current treatment guidelines and treatment options, in addition to approved therapies for Whiplash Injury in the US, Europe, and Japan?
• What are the key collaborations (Industry–Industry, Industry-Academia), mergers and acquisitions, and licensing activities related to Whiplash Injury therapies?
• What are the recent novel therapies, targets, mechanisms of action, and technologies being developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Whiplash Injury and its status, along with the challenges faced?

 

Reasons to Buy

• The patient-based Whiplash Injury market forecasting analysis will help in developing business strategies by understanding trends shaping and driving the Whiplash Injury market
• Organize sales and marketing efforts by identifying the best opportunities for Whiplash Injury in the US, Europe (Germany, Spain, Italy, France), and the United Kingdom, and Japan
• Identification of strong upcoming players in the market that will help devise strategies that will help in getting ahead of competitors